Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) Spring Scientific 2025 Cell Therapy Meeting
-
Trump says he trusts Putin, as UK PM pushes Ukraine guarantees
-
Influencer Andrew Tate in US despite charges in Romania
-
UN nature talks 'close' to breaking funding deadlock
-
Spassky: legendary loser of 'match of the century' dies at 88
-
Israel army says failed on Oct 7, underestimated Hamas
-
German conservatives, SPD to make first moves towards new govt
-
Mexican president hopes to talk with Trump to avoid tariffs
-
Angry Medvedev squanders four match points, crashes out in Dubai
-
The risks of Trump tariffs encapsulated in a car key
-
Ireland's Ringrose banned for Six Nations showdown against France
-
King Charles III invites Trump for unprecedented second state visit
-
Second day of health improvements for Pope Francis, reports Vatican
-
Let me entertain you, says Duplantis
-
Hungary will no longer 'tolerate' public Pride march
-
US study highlights success story of HPV vaccination
-
Trump tariffs pose challenge for Europe's carmakers
-
UK's Starmer meets Trump to push for Ukraine guarantees
-
Double-shift Sainz tops Bahrain F1 testing times
-
Influencer Andrew Tate facing charges in Romania arrives in US
-
Sinner dropped from Laureus awards list after doping ban
-
Trump says China to face added 10% tariff starting in March
-
Double-shift Sainz tops Bahrain testing times
-
Toronto Pride says sponsors bolting over Trump's anti-DEI push
-
Explosions at M23 rally in east DR Congo kill at least 11
-
Hollywood giant Gene Hackman, wife found dead in 'suspicious' circumstances
-
'So much anxiety': Trump migrant crackdown vow stirs fear in NY
-
How did this man's brain turn to glass? Scientists have a theory
-
Accused of repression, Nicaragua's Ortega swears in hooded 'volunteer' force
-
Peppa Pig to get new sibling
-
After 45 years, Palestinian prisoner freed from Israeli jail in latest swap
-
In major shift, Ocalan calls for PKK to drop weapons, disband
-
Russia says annexation of Ukrainian land is 'non-negotiable'
-
Seoul says North Korea has deployed more troops to Russia
-
England lock Martin ruled out of rest of Six Nations
-
Influencer Andrew Tate facing charges in Romania leaves for US
-
A French-UK nuclear umbrella for Europe? Not likely, say analysts
-
Former African leaders launch debt relief drive for poor nations
-
Baby, you're a firework! Katy Perry to blast off into space
-
EU will 'do the same' if US imposes tariffs hikes: French finance minister to AFP
-
UK's Starmer pushes Trump for Ukraine guarantees against Putin
-
East DR Congo explosions kill at least 11
-
Israel sends negotiators after Hamas hands over hostage bodies
-
European stock markets slide as Trump targets EU with tariffs
-
Ocalan: Kurdish PKK founder who urged his fighters to disarm
-
England's limp Champions Trophy exit underlines sharp decline
-
For Tour de France foreign starts are a money-spinner
-
Hollywood giant Gene Hackman and wife found dead at home
-
Legendary Irish trio to retire at end of Six Nations
-
Hong Kong pro-democracy lawmaker jailed over 2019 mob attack
-
Russia says talks on annexed Ukrainian land 'non-negotiable'
NYSE - LSE
| RBGPF | 3.4% | 67.13 | $ | |
| CMSC | 0.34% | 23.66 | $ | |
| SCS | -2.22% | 12.15 | $ | |
| CMSD | 0.3% | 23.72 | $ | |
| RIO | -0.9% | 61.03 | $ | |
| NGG | -1.29% | 61.766 | $ | |
| BCC | -0.57% | 103.48 | $ | |
| GSK | -0.25% | 37.305 | $ | |
| RYCEF | 13.3% | 9.25 | $ | |
| RELX | -0.87% | 47.835 | $ | |
| VOD | 0.68% | 8.76 | $ | |
| BCE | 0.55% | 23.49 | $ | |
| AZN | 0.15% | 75.63 | $ | |
| JRI | 0.31% | 12.77 | $ | |
| BP | 2.01% | 33.351 | $ | |
| BTI | 0.16% | 38.921 | $ |
Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) Spring Scientific 2025 Cell Therapy Meeting
FRAMINGHAM, MA / ACCESS Newswire / February 27, 2025 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers, today announced that its abstract has been accepted for poster presentation at the Society for Immunotherapy of Cancer (SITC) Spring Scientific 2025 Cell Therapy Meeting being held March 12 - 14, 2025 in San Diego, CA and virtually.
Details for the presentation are as follows:
Abstract Number: 123
Title: DNase I Intervention Enhances CAR-T Cell Therapy in Solid Tumors by Targeting Neutrophil Extracellular Traps in Metastatic Melanoma
Presenter: Alexey Stepanov, PhD, Institute Investigator at The Scripps Research Institute
Date & Time: Wednesday, March 12, 2025 at 5:10 p.m. - 6:45p.m. PT
For more information, please visit the conference website here.
About Xenetic Biosciences
Xenetic Biosciences, Inc. is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is currently focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and locally advanced or metastatic solid tumors.
For more information, please visit the Company's website at www.xeneticbio.com and connect on X, LinkedIn, and Facebook.
Contact:
JTC Team, LLC
Jenene Thomas
(908) 824-0775
[email protected]
SOURCE: Xenetic Biosciences, Inc.
View the original press release on ACCESS Newswire
J.Oliveira--AMWN
